What to do about the problem of non-FDA approved compounded bioidentical hormones

Update: 2018-08-20

Description

How does Dr. Stuenkel recommend the problem of increased compounded hormone therapy use be addressed?

Comments

In Channel

New and promising GSM treatments, more clinical takeaways from NAMS 2018

2018-10-1722:19

Addressing your patient's sexual function after cancer

2018-10-0408:26

Maternal immunization: What does the future hold?

2018-09-1105:34

Which IUD is right for me? Answering your patients' questions about differences in LNG-IUDs

2018-08-2006:47

Managing menopausal symptoms in breast cancer survivors

2018-08-2010:49

New single-dose treatment for bacterial vaginosis

2018-08-2005:49

Tips for performing complex laparoscopic gyn surgery

2018-08-2005:18

Tackling opioids and maternal health in US Congress

2018-08-2014:55

Your patient has a large symptomatic fibroid: Tools for decision making

2018-08-2003:14

Clinical pearls from NAMS 2017

2018-08-2006:03

What to do about the problem of non-FDA approved compounded bioidentical hormones

2018-08-2009:40

Obesity medicine: How to incorporate it into your practice

2018-08-2006:28

Bacterial vaginosis: Meet patients' needs with effective diagnosis and treatment

2018-08-2010:58

Is burnout on the rise and what are the signs ObGyns should be on the lookout for?

2018-08-2011:06

00:00

#box-pro-ellipsis-176185749151662{-webkit-line-clamp:2;}What to do about the problem of non-FDA approved compounded bioidentical hormones